JKE-1716 is a potent and selective nitrolic acid-containing GPX4 inhibitor. JKE-1716 is able of inducing ferroptosis selectively through covalent GPX4 inhibition.
In Vitro Activity
JKE-1716 (0~100 nΜ; 72 hours; LOX-IMVI cells) inhibits cell viability.
JKE-1716 (LOX-IMVI cells) inhibits the expression of α-GPX4.
Storage & Handling
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Shipping
Room temperature in continental US; may vary elsewhere.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.